Entresto 97 MG-103 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3UFG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,586
Award facts
- Contract value 100% obligated
- $18,586.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a competitively competed, non-set-aside delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Entresto 97 mg-103 mg tablets (60-count) with a contract ceiling value of $18,586.25 and an ultimate completion date of January 26, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under the company's parent organization Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, enabling the supply of comprehensive pharmaceutical products and medical commodities to support military healthcare programs globally.
Entresto, a cardiovascular medication used in heart failure treatment, represents one of many pharmaceutical products that AmerisourceBergen supplies through its extensive federal contract portfolio with the Defense Logistics Agency. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its significant prime vendor contract vehicle, positions it as a key supplier within the military healthcare supply chain. This delivery order exemplifies the routine execution of federal medical procurement under the broader pharmaceutical supply framework supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F3UFG?
SPE2DR26F3UFG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F3UFG worth?
The government has obligated $18,586 on SPE2DR26F3UFG.
Is contract SPE2DR26F3UFG an order under another contract?
Yes. SPE2DR26F3UFG is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UFG competed?
The extent of competition for SPE2DR26F3UFG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award